research Hormonal Profile of Men with Premature Balding
Men with early balding often have hormone levels similar to women with polycystic ovary syndrome.
Search
for
Sort by
Research
990-1000 / 1000+ results 
research Association of Polycystic Ovary Syndrome and Graves' Disease: Is Autoimmunity the Link Between the Two Diseases?
The document suggests that there might be an autoimmune link between polycystic ovary syndrome and Graves' disease.
research Pilot Study of a Novel Treatment for Androgenetic Alopecia Using Enriched Cell Culture Medium: Clinical Trials
A new treatment for hair loss was tested and most participants saw their hair loss stop within 2-8 weeks, with up to 50% more hair after 4 months, and no side effects.
research Hirsutism in Women: Causes, Diagnosis, and Treatment Options
Hirsutism in women is mostly caused by polycystic ovary syndrome and idiopathic hyperandrogenism.
research Serum AMH Levels in the Differential Diagnosis of Hyperandrogenemic Conditions
Blood AMH levels are higher in women with PCOS than in those with other similar conditions.
research A Patient With Combined Polycystic Ovary Syndrome And Autoimmune Polyglandular Syndrome Type 2
A woman was the first known case to have both polycystic ovary syndrome and autoimmune polyglandular syndrome type 2, suggesting a need to check for both conditions in similar patients.
research Diffuse Scalp Hair Loss Due to Levothyroxine Overdose
Too much levothyroxine can cause hair loss in infants.
research Hypothyroidism in a Dog: A Case Report
The dog recovered from hypothyroidism and regrew its hair after two months of treatment.
research Clinical, Trichoscopic, and Histopathologic Characteristics of Patients with Alopecia and Hypothyroidism: An Observational Study
Hypothyroidism patients with hair loss typically have thinning hair, smaller hair follicles, and normal hair shedding.
research Shock: A Possible Presenting Manifestation of Autoimmune Polyendocrine Syndrome Type II
Shock can be an early sign of Autoimmune Polyendocrine Syndrome Type II.